08 Sep 2022 Governance
Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II
On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement:
“We are extremely saddened to hear the news of the death of Her Majesty Queen Elizabeth II. 
Together with the nation and people around the world, we remember a true leader who gave her life to duty. The Queen’s dedication, diligence and integrity were an inspiration to all and we are thankful for an inspiring monarch, who gave her life in service of her country and the Commonwealth.
The Queen’s support for the charity sector has enabled charities in the UK to thrive during her reign and will have a lasting impact for those whom the charities support.
We share our condolences with the entire Royal Family and especially the Queen’s children and grandchildren. Our thoughts are with them at this very difficult time.”
Related posts
14 March 2023
Percy & Nell says Pants to Leukaemia with bespoke charity collaboration
Independent clothing brand Percy & Nell has produced a unique range of sweatshirts, t-shirts, beanies and tote bags, with all profits going to Leukaemia UK. The collaboration comes off the…
6 March 2024
TV baker Juliet Sear announced as Leukaemia UK Ambassador
Leukaemia UK is excited to announce long-time supporter Juliet Sear as their latest celebrity Ambassador. Juliet, who has been an enthusiastic supporter of Leukaemia UK for several years now, wanted…
15 February 2024
Parents join Leukaemia UK in calling for more donations to fund research to stop blood cancer ‘destroying childhoods’
Parents of children whose lives have been devastated by leukaemia have joined Leukaemia UK on International Childhood Cancer Day (February 15th) in calling for more research into the blood cancer. …
10 January 2023
Clinical trial begins for pioneering new cancer treatment
Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.